Epidemiological analysis of critically ill adult patients with pandemic influenza A(H1N1) in South Korea

Epidemiology and Infection

Volumn 141, Issue 5, 2013, Pages 1070-1079

  Hong, S B ^a   Choi, E Y ^a   Kim, S H ^a   Suh, G Y ^b   Park, M S ^c   Lee, M G ^d   Lim, J ^a   Lee, H K ^e   Kim, S C ^f   Kim, S J ^g   Kim, K U ^h   Kwak, S H ⁱ   Koh, Y ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c Yonsei University   (South Korea)

^d Hallym University   (South Korea)

^e Inje University   (South Korea)

^f The Catholic University of Korea   (South Korea)

^g Konkuk University School of Medicine   (South Korea)

^h Pusan National University School of Medicine   (South Korea)

ⁱ Chonnam National University Medical School   (South Korea)

Author keywords

Critical illness; H1N1 subtype; influenza A virus; Korea

Indexed keywords

AMANTADINE; CORTICOSTEROID; OSELTAMIVIR; RIBAVIRIN;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; AGE; AGED; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL PNEUMONIA; BODY MASS; CHRONIC LUNG DISEASE; CLINICAL DECISION MAKING; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIABETES MELLITUS; FEMALE; HOSPITAL INFECTION; HUMAN; HYPERTENSION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL RECORD REVIEW; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PANDEMIC INFLUENZA; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SMOKING; SOUTH KOREA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; CRITICAL ILLNESS; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; REPUBLIC OF KOREA; RISK FACTORS; YOUNG ADULT;

EID: 84876002493     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268812001604     Document Type: Article

References (39)

1. Centers for Disease Control and Prevention (CDC). Swine influenza A (H1N1) infection in two children-Southern California, March-April 2009. Morbidity and Mortality Weekly Report 2009; 58: 400-402.
2. World Health Organization. Global alert and response, pandemic (H1N1) 2009, frequently asked questions: what is Phase 6? (http://www.who.int/csr/). Accessed 11 June 2009.
3. Korea Centers for Disease Control and Prevention. Newsletter for influenza. (http://www.cdc.go.kr/). Accessed 11 May 2009.
4. Dominguez-Cherit G, et al. Critically ill patients with 2009 influenza A (H1N1) in Mexico. Journal of the American Medical Association 2009; 302: 1880-1887.
5. Kumar A, et al. Critically ill patients with 2009 influenza A (H1N1) infection in Canada. Journal of the American Medical Association 2009; 302: 1872-1879.
6. Louie JK, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A (H1N1) infection in California. Journal of the American Medical Association 2009; 302: 1896-1902.
7. Rello J, et al. Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1) in Spain. Critical Care 2009; 13: R148.
8. Estenssoro E, et al. Pandemic 2009 influenza A in Argentina: A study of 337 patients on mechanical ventilation. American Journal of Respiration and Critical Care Medicine 2010; 182: 41-48.
9. Davies A, et al. Extracorporeal membrane oxygenation for 2009 influenza A (H1N1) acute respiratory distress syndrome. Journal of the American Medical Association 2009; 302: 1888-1895.
10. Hancock K, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. New England Journal of Medicine 2009; 361: 1945-1952.
11. Fuhrman C, et al. Adult intensive care patients with 2009 pandemic influenza A (H1N1) infection. Epidemiology and Infection 2011; 139: 1202-1209.
12. Viasus D, et al. Factors associated with severe disease in hospitalized adults with pandemic (H1N1) 2009 in Spain. Clinical Microbiology and Infection 2011; 17: 738-746.
13. Kim JH, et al. The spread of pandemic H1N1 2009 by age and region and the comparison among monitoring tools. Journal of Korean Medical Science 2010; 25: 1109-1112.
14. Shin SY, et al. Clinical characteristics of Korean pediatric patients critically ill with influenza A (H1N1) virus. Pediatric Pulmonology 2010; 45: 1014-1020.
15. Kim HS, et al. Fatal cases of 2009 pandemic influenza A (H1N1) in Korea. Journal of Korean Medical Science 2011; 26: 22-27.
16. Echevarria-Zuno S, et al. Infection and death from influenza A H1N1 virus in Mexico: A retrospective analysis. Lancet 2009; 374: 2072-2079.
17. Sundar S, et al. Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010). Clinical Infectious Disease 2011; 52 (Suppl. 1) : S75-S82.
18. Miller MA, et al. The signature features of influenza pandemics-implications for policy. New England Journal of Medicine 2009; 360: 2595-2598.
19. Gooskens J, et al. Morbidity and mortality associated with nosocomial transmission of oseltamivir-resistant influenza A (H1N1) virus. Journal of the American Medical Association 2009; 301: 1042-1046.
20. Cunha BA, Thekkel V, Krilov L. Nosocomial swine influenza (H1N1) pneumonia: lessons learned from an illustrative case. Journal of Hospital Infection 2010; 74: 278-281.
21. Nicoll A. A new decade, a new seasonal influenza: The Council of the European Union recommendation on seasonal influenza vaccination [Editorial]. Eurosurveillance 2010; 15: 1-2.
22. Poalillo FE, Geiling J, Jimenez EJ. Healthcare personnel and nosocomial transmission of pandemic 2009 influenza. Critical Care Medicine 2010; 38 (Suppl. 4) : e98-102.
23. Vaillant L, et al. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Eurosurveillance 2009; 14: 1-6.
24. Louie JK, et al. A novel risk factor for a novel virus : obesity and 2009 pandemic influenza A (H1N1). Clinical Infectious Disease 2011; 52: 301-312.
25. Yu H, et al. Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China. Clinical Infectious Disease 2011; 52: 457-465.
26. Cooksley CD, et al. Epidemiology and outcomes of serious influenza-related infections in the cancer population. Cancer 2005; 104: 618-628.
27. Zarychanski R, et al. Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection. Canadian Medical Association Journal 2010; 182: 257-264.
28. Chien YS, et al. Predictors and outcomes of respiratory failure among hospitalized pneumonia patients with 2009 H1N1 influenza in Taiwan. Journal of Infection 2010; 60: 168-174.
29. Yu H, et al. Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China. British Medical Journal 2010; 341: c4779.
30. Jefferson T, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults : systematic review and meta-analysis. British Medical Journal 2009; 339: b5106.
31. Garnacho-Montero J, et al. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Critical Care Medicine 2003; 31: 2742-2751.
32. Abdel-Ghafar AN, et al. Update on avian influenza A (H5N1) virus infection in humans. The New England Journal of Medicine 2008; 358: 261-273.
33. Nguyen JT, et al. Triple combination of oseltamivir, amantadine, and ribavirin displays synergistic activity against multiple influenza virus strains in vitro. Antimicrobial Agents and Chemotherapy 2009; 53: 4115-4126.
34. Martin-Loeches I, et al. Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1) influenza A infection. Intensive Care Medicine 2011; 37: 272-283.
35. Xu T, et al. Effect of dexamethasone on acute respiratory distress syndrome induced by the H5N1 virus in mice. European Respiration Journal 2009; 33: 852-860.
36. Lee N, et al. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. Journal of Infectious Disease 2009; 200: 492-500.
37. Sprung CL, et al. Hydrocortisone therapy for patients with septic shock. New England Journal of Medicine 2008; 358: 111-124.
38. Cronin L, et al. Corticosteroid treatment for sepsis : A critical appraisal and meta-analysis of the literature. Critical Care Medicine 1995; 23: 1430-1439.
39. Sprung CL, et al. The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. New England Journal of Medicine 1984; 311: 1137-1143.